Tom Brown | |
---|---|
Born | [1] Barnsley, West Riding of Yorkshire, England | 10 November 1952
Nationality | British |
Alma mater | University of Bradford |
Known for | DNA Repair, Molecular genetics, DNA Click chemistry, Primerdesign |
Awards |
|
Scientific career | |
Fields | Chemical biology, Nanotechnology |
Institutions | University of Oxford University of Southampton University of Edinburgh |
Thesis | The chemistry of some imidazoles. (1979) |
Doctoral advisor | Gordon Shaw |
Other academic advisors | Olga Kennard OBE FRS |
Website | browngroupnucleicacidsresearch |
Tom Brown FRSC [2] FRSE [3] (born 10 November 1952) is a British chemist, biotechnologist, and entrepreneur. He is the Professor of Nucleic acid chemistry at the Department of Chemistry [6] and Department of Oncology [7] at the University of Oxford. Currently, he is serving as the President of the Chemical Biology Interface Division of the Royal Society of Chemistry. [8] He is best known for his contribution in the field of DNA Repair, [9] [10] DNA Click chemistry, [11] [12] [13] and in the application of Molecular genetics in forensics and diagnostics. [14] [15] [16]
He co-founded three biotechnology companies: Oswel Research Products, ATDBio, and Primerdesign. [17] [18] As of January 2016, he is in the board of directors of last two. [19] [20]
Brown was born in Barnsley, West Riding of Yorkshire, and attended Broadway Grammar School there. As an undergraduate student, he attended University of Bradford to study chemistry where he obtained his bachelor's degree with first class honours, and was awarded the Griffin and George Prize for being the most outstanding graduate. In 1979, he earned his PhD from the same university, under the supervision of Prof Gordon Shaw. He then carried out his post-doctoral research at the University of Nottingham (with Leslie Crombie and Gerry Pattenden), University of Oxford (with John Jones), and at the University of Cambridge (with Olga Kennard OBE FRS). [1] [5]
After these post-doctoral stints, he was appointed as a Lecturer at the University of Edinburgh where he was subsequently promoted to the rank of Reader and then to Professor. In 1995, he moved to the University of Southampton where he worked as a Professor of Chemical Biology. [21] In 2013, Brown again moved, to take up position of the Professor of Nucleic acid chemistry at the University of Oxford where he now holds a joint position at the Department of Chemistry and Department of Oncology. [1] [5] [6] [7] In 2014, he was elected as the President of the Chemical Biology Interface Division of the Royal Society of Chemistry for a term of three years. [8]
In early part of his academic career, Brown studied base-pair mismatch and DNA repair. [22] [23] Later he worked on the mutagenic effect of chemically modified DNA bases. In collaboration with Laurence Pearl, he elucidated the structural basis of excision repair by Uracil-DNA glycosylase. [9] His group is also well known for rapid mutation analysis and for the application of Molecular genetics in forensics [14] [24] and diagnostics. [15] [16] In collaboration with AstraZeneca, they invented Scorpion Primers system, a fluorescence-based real-time PCR method that can identify mutations and Single-nucleotide polymorphism in human genome. [25] [26] [27] Most recently, his group is focusing on the Click chemistry based chemical modification of DNA and its application in bionanotechnology sector. [11] [12] [13] [28]
As of January 2016, Brown has published more than 300 articles in peer-reviewed journals, with many of his papers appearing in highly selective journals like Nature, Nature Biotechnology, Cell, Nucleic Acids Research, JACS, and PNAS. His papers have been cited over 18,000 times and he has an h-index 68. [29]
Brown was elected as a fellow of the Royal Society of Chemistry [2] and Royal Society of Edinburgh. [3]
Apart from that, he has received the following major honours in recognition of his research work:
While working at the University of Edinburgh, Brown founded Oswel Research Products (the name 'Oswel' came from "Oligonucleotide synthesis" and "Wellcome Trust"), a company which was dedicated to automated DNA synthesis. [17] Later, in 1995, the company moved to Southampton, along with Brown. In the year 1999, when the company had turnover of GBP 2.2 million and a profit of GBP 0.7 million, Eurogentec acquired Oswel. [37] [38]
In 2004, Brown co-founded (along with two of his University of Southampton colleagues) Primerdesign, a company which designs and manufactures products for quantitative Real-time polymerase chain reaction. [39] [17] [20] The company is best known for creating rapid Swine Flu detection kit in 2009, and for creating a test for the SARS-CoV-2 virus strain in 2020. [40] [41] [42] [43] [44] [45]
In 2005, Brown founded ATDBio with an aim to synthesize chemically modified oligonucleotides for technical applications. As of June 2014, this company maintains two different labs at Southampton and Oxford. [17] [19]
Frederick Sanger was a British biochemist who twice won the Nobel Prize in Chemistry, one of only two people to have done so in the same category, the fourth person overall with two Nobel Prizes, and the third person overall with two Nobel Prizes in the sciences. In 1958, he was awarded a Nobel Prize in Chemistry "for his work on the structure of proteins, especially that of insulin". In 1980, Walter Gilbert and Sanger shared half of the chemistry prize "for their contributions concerning the determination of base sequences in nucleic acids". The other half was awarded to Paul Berg "for his fundamental studies of the biochemistry of nucleic acids, with particular regard to recombinant DNA".
Alexander Robertus Todd, Baron Todd was a Scottish biochemist whose research on the structure and synthesis of nucleotides, nucleosides, and nucleotide coenzymes gained him the Nobel Prize for Chemistry.
A locked nucleic acid (LNA), also known as bridged nucleic acid (BNA), and often referred to as inaccessible RNA, is a modified RNA nucleotide in which the ribose moiety is modified with an extra bridge connecting the 2' oxygen and 4' carbon. The bridge "locks" the ribose in the 3'-endo (North) conformation, which is often found in the A-form duplexes. This structure can be attributed to the increased stability against enzymatic degradation; moreover the structure of LNA has improved specificity and affinity as a monomer or a constituent of an oligonucleotide. LNA nucleotides can be mixed with DNA or RNA residues in the oligonucleotide, in effect hybridizing with DNA or RNA according to Watson-Crick base-pairing rules.
Jacqueline K. Barton, is an American chemist. She worked as a Professor of Chemistry at Hunter College (1980–82), and at Columbia University (1983–89) before joining the California Institute of Technology. In 1997 she became the Arthur and Marian Hanisch Memorial Professor of Chemistry and from 2009 to 2019, the Norman Davidson Leadership Chair of the Division of Chemistry and Chemical Engineering at Caltech. She currently is the John G. Kirkwood and Arthur A. Noyes Professor of Chemistry.
Sir Richard John Roberts is a British biochemist and molecular biologist. He was awarded the 1993 Nobel Prize in Physiology or Medicine with Phillip Allen Sharp for the discovery of introns in eukaryotic DNA and the mechanism of gene-splicing. He currently works at New England Biolabs.
Sir Gregory Paul Winter is a Nobel Prize-winning British molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering, in Cambridge, England.
Sir Edwin Mellor Southern is an English Lasker Award-winning molecular biologist, Emeritus Professor of Biochemistry at the University of Oxford and a fellow of Trinity College, Oxford. He is most widely known for the invention of the Southern blot, published in 1975 and now a common laboratory procedure.
Frank Henry Westheimer was an American chemist. He taught at the University of Chicago from 1936 to 1954, and at Harvard University from 1953 to 1983, becoming the Morris Loeb Professor of Chemistry in 1960, and Professor Emeritus in 1983. The Westheimer medal was established in his honor in 2002.
Peter B. Dervan is the Bren Professor of Chemistry at the California Institute of Technology. The primary focus of his research is the development and study of small organic molecules that can sequence-specifically recognize DNA, a field in which he is an internationally recognized authority. The most important of these small molecules are pyrrole–imidazole polyamides. Dervan is credited with influencing "the course of research in organic chemistry through his studies at the interface of chemistry and biology" as a result of his work on "the chemical principles involved in sequence-specific recognition of double helical DNA". He is the recipient of many awards, including the National Medal of Science (2006).
Tomas Robert Lindahl FRS FMedSci is a Swedish-British scientist specialising in cancer research. In 2015, he was awarded the Nobel Prize in Chemistry jointly with American chemist Paul L. Modrich and Turkish chemist Aziz Sancar for mechanistic studies of DNA repair.
Sir Shankar Balasubramanian is an Indian-born British chemist and Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College, Cambridge. He is recognised for his contributions in the field of nucleic acids. He is scientific founder of Solexa and Cambridge Epigenetix.
Xeno nucleic acids (XNA) are synthetic nucleic acid analogues that have a different sugar backbone than the natural nucleic acids DNA and RNA. As of 2011, at least six types of synthetic sugars have been shown to form nucleic acid backbones that can store and retrieve genetic information. Research is now being done to create synthetic polymerases to transform XNA. The study of its production and application has created a field known as xenobiology.
Donald Crothers was a professor of chemistry at Yale University in the United States. He was best known for his work on nucleic acid structure and function.
James Henderson Naismith is Professor of Structural Biology at the University of Oxford, former Director of the Research Complex at Harwell and Director of the Rosalind Franklin Institute. He previously served as Bishop Wardlaw Professor of Chemical Biology at the University of St Andrews.
Sir David Klenerman is a British biophysical chemist and a professor of biophysical chemistry at the Department of Chemistry at the University of Cambridge and a Fellow of Christ's College, Cambridge. He is best known for his contribution in the field of next-generation sequencing of DNA, nanopipette-based scanning ion-conductance microscopy, and super-resolution microscopy.
Paul Martin Sharp is Professor of Genetics at the University of Edinburgh, where he holds the Alan Robertson chair of genetics in the Institute of Evolutionary Biology.
Christopher Joseph Schofield is the Head of Organic Chemistry at the University of Oxford and a Fellow of the Royal Society. Chris Schofield is a professor of organic chemistry at the University of Oxford, Department of Chemistry and a Fellow of Hertford College. Prof Schofield studied functional, structural and mechanistic understanding of enzymes that employ oxygen and 2-oxoglutarate as a co-substrate. His work has opened up new possibilities in antibiotic research, oxygen sensing, and gene regulation.
John Masson Gulland was a Scottish chemist and biochemist. His main work was on nucleic acids, morphine and aporphine alkaloids. His work at University College Nottingham on electrometric titration was important in leading to the discovery of the DNA double helix by James Watson and Francis Crick, and he was described as "a great nucleic acid chemist." He established the Scottish Seaweed Research Association and the Lace Research Council.
Marvin H. Caruthers is an American biochemist who is a Distinguished Professor at the University of Colorado Boulder.
Michal Hocek is a Czech chemist. He is a group leader at the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and a professor of organic chemistry at Charles University in Prague. He specializes in the chemistry and chemical biology of nucleosides, nucleotides, and nucleic acids.